Dual Drug Therapy (alpha-blocker + 5-alpha-reductase inhibitor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual Drug Therapy (alpha-blocker + 5-alpha-reductase inhibitor), covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men [NA]